Moritz Maas
Tuebingen, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Urine Tumor DNA Testing Identifies Recurrence and Monitors Therapy Response in Patients With High-Risk Nonmuscle-Invasive Bladder Cancer Receiving Intravesical Bacillus Calmette-Guérin.
Journal: The Journal of urology
Published: May 20, 2026
Closing the diagnostic gap in upper tract urothelial carcinoma: the emerging role of urinary multiplex biomarkers.
Journal: Translational andrology and urology
Published: March 30, 2026
Nectin-4 expression in clear cell renal cell carcinoma.
Journal: Scientific reports
Published: March 26, 2026
Excellent Response to Combined 223 Ra-dichloride and Enzalutamide After Failure of 177 Lu-PSMA Radioligand Therapy.
Journal: Clinical nuclear medicine
Published: January 24, 2026
Recurrence patterns in primary urethral carcinoma: Prognostic impact of inguinal and pelvic lymphadenectomy.
Journal: Urologic oncology
Published: November 01, 2025
Patient-derived bladder cancer organoids show stable transcript expression along cultivation.
Journal: World journal of urology
Published: May 20, 2024
The optimal number of induction chemotherapy cycles in clinically lymph node-positive bladder cancer.
Journal: BJU international
Published: March 12, 2024
Ex vivo Study of Partial Bladder Resection in a Porcine Model.
Journal: Urologia internationalis
Published: March 10, 2024
PD-L1 Expression in High-Risk Non-Muscle-Invasive Bladder Cancer Is Influenced by Intravesical Bacillus Calmette-Guérin (BCG) Therapy.
Journal: Cancers
Published: February 13, 2024
Last Updated: 09/26/2026